Jad Chahoud, Chief Scientific and Innovation Officer at Orlando Health Cancer Institute, shared a post on LinkedIn:
“Excited to welcome Dr. Fawzi Abu Rous to OHCI Orlando Health Grand Rounds this Monday, April 6 at 5:30 PM at ORMC MPRs․
A leader in early therapeutics and thoracic oncology, Dr. Abu Rous, Henry Ford Health will share insights on ՛Drug Development: From First-In-Human to FDA Approval՛ a timely and powerful look at how innovative cancer therapies move from concept to clinical impact.”
Other articles about drug development on OncoDaily.